Prof.-Ernst-Nathan-Str. 1
90419 Nürnberg
Phone:0911-3980
Mail:ed.grebnreun-mukinilk@elletsesserp
Basic information
- Number of beds: 1.220
- Number of specialist departments: 25
- Number of inpatient cases: 44.728
- Number of partial inpatient cases: 2.564
- Number of outpatient cases: 87.153
- Hospital owners: Klinikum Nürnberg - gemeinnützige Anstalt des öffentlichen Rechts
- Type of provider: öffentlich
Specialist departments
- Klinik für Allgemein-, Viszeral- und Thoraxchirurgie, Universitätsklinik der Paracelsus Medizinischen Privatuniversität
- Klinik für Dermatologie, Universitätsklinik der Paracelsus Medizinischen Privatuniversität - Tagesklinik
- Klinik für Hals-Nasen-Ohrenheilkunde, Universitätsklinik der Paracelsus Medizinischen Privatuniversität
- Klinik für Urologie, Universitätsklinik der Paracelsus Medizinischen Privatuniversität
- Klinik für Frauenheilkunde Universitätsklinik der Paracelsus Medizinischen Privatuniversität - Schwerpunkt Gynäkologie
- Klinik für Augenheilkunde, Universitätsklinik der Paracelsus Medizinischen Privatuniversität
- Klinik für Psychiatrie und Psychotherapie, Universitätsklinik der Paracelsus Medizinischen Privatuniversität
- Klinik für Psychiatrie und Psychotherapie, Universitätsklinik der Paracelsus Medizinischen Privatuniversität - Tagesklinik
- Klinik für Psychosomatische Medizin und Psychotherapie, Universitätsklinik der Paracelsus Medizinischen Privatuniversität
- Klinik für Psychosomatische Medizin und Psychotherapie, Universitätsklinik der Paracelsus Medizinischen Privatuniversität - Tagesklinik
- Klinik für Psychiatrie, Psychosomatik und Psychotherapie im Kindes- und Jugendalter
- Notaufnahme und Fast Track, Klinikum Nord
- Klinik für Psychiatrie, Psychosomatik und Psychotherapie im Kindes- und Jugendalter - Tagesklinik
- Klinik für Anästhesiologie und operative Intensivmedizin, Universitätsklinik der Paracelsus Medizinischen Privatuniversität
- Interdisziplinäre Schmerztagesklinik
- Institut für Radiologie, Neuroradiologie und Nuklearmedizin, Universitätsklinik der Paracelsus Medizinischen Privatuniversität – Standort Nord, Nuklearmedizin
- Abteilung für Strahlentherapie
- Institut für Radiologie, Neuroradiologie und Nuklearmedizin, Universitätsklinik der Paracelsus Medizinischen Privatuniversität – Standort Nord, Radiologie
- Klinik für Innere Medizin 2, Schwerpunkt Geriatrie, Universitätsklinik der Paracelsus Medizinischen Privatuniversität
- Klinik für Innere Medizin 2, Schwerpunkt Geriatrie, Universitätsklinik der Paracelsus Medizinischen Privatuniversität - Tagesklinik
- Klinik für Innere Medizin 3, Schwerpunkt Pneumologie, Allergologie, Schlafmedizin, Universitätsklinik der Paracelsus Medizinisch
- Klinik für Innere Medizin 5, Schwerpunkt Onkologie/Hämatologie, Universitätsklinik der Paracelsus Medizinischen Privatuniversität
- Klinik für innere Medizin 6, Schwerpunkte Gastroenterologie, Endokrinologie,
- Klinik für Innere Medizin 8, Schwerpunkt Kardiologie. Universitätsklinik der Paracelsus Medizinischen Privatuniversität
- Klinik für Dermatologie, Universitätsklinik der Paracelsus Medizinischen Privatuniversität
Services
- Medical services
- Medical and nursing services
Quality
External comparative quality assurance
Further information
- External quality assurance according to state law
No participation
- Quality of participation in the Disease Management Programme (DMP)
No participation
Implementation of the minimum quantity agreement
Treatment area
Complex interventions on the organ system esophagus for adults
| Quantity performed | 71 |
| Exception? | No exception |
Complex operations on the pancreatic organ system
| Quantity performed | 78 |
| Exception? | No exception |
Stem cell transplant
| Quantity performed | 94 |
| Exception? | No exception |
Minimum quantities forecast
Surgical treatment of breast cancer (mamma surgery)
| Overall result forecast presentation: | yes |
| Quantity performed reporting year: | 541 |
| Quantity forecast year: | 527 |
| Examination by state associations? | yes |
| Exemption? | yes |
| Result of the examination by the federal state authorities? | yes |
| Transitional arrangement? | no |
Complex interventions on the organ system esophagus for adults
| Overall result forecast presentation: | yes |
| Quantity performed reporting year: | 71 |
| Quantity forecast year: | 56 |
| Examination by state associations? | yes |
| Exemption? | yes |
| Result of the examination by the federal state authorities? | yes |
| Transitional arrangement? | no |
Complex operations on the pancreatic organ system
| Overall result forecast presentation: | yes |
| Quantity performed reporting year: | 78 |
| Quantity forecast year: | 81 |
| Examination by state associations? | yes |
| Exemption? | yes |
| Result of the examination by the federal state authorities? | yes |
| Transitional arrangement? | no |
Stem cell transplant
| Overall result forecast presentation: | yes |
| Quantity performed reporting year: | 94 |
| Quantity forecast year: | 110 |
| Examination by state associations? | yes |
| Exemption? | yes |
| Result of the examination by the federal state authorities? | yes |
| Transitional arrangement? | no |
Thoracic surgical treatment of lung cancer in adults
| Overall result forecast presentation: | yes |
| Quantity performed reporting year: | 141 |
| Quantity forecast year: | 152 |
| Examination by state associations? | yes |
| Exemption? | yes |
| Result of the examination by the federal state authorities? | yes |
| Transitional arrangement? | no |
- Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation
Compliance with staffing requirements
- Clarifying chat completed: no
- Clarifying chat not completed: no
- No participation in clarifying chat: no
- Notification of non-fulfilment of nursing care not made: no
Further trainingpursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB
| Number | Group |
|---|---|
| 381 | Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training* |
| 40 | Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence |
| 17 | Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations |
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”
General information
- Accessibility
- Hygiene
- Quality management and risk management
Protection concept against (sexual) violence against children and young people
Advice on prevention and intervention in cases of violence and abuse
According to Section 4 (2) of the Quality Management Guideline, facilities must provide for the prevention of and intervention in cases of violence and abuse as part of their internal quality management. The aim is to prevent, recognise and respond appropriately to abuse and violence, particularly against vulnerable patient groups such as children and adolescents or people in need of help, and also to prevent it within the facility. The respective procedure is aligned with the size of the facility, the range of services and the patients in order to define customised solutions for sensitising the teams as well as other suitable preventative and interventional measures. These may include information materials, contact addresses, training/education, codes of conduct, recommendations for action/intervention plans or comprehensive protection concepts.
- Is a protection concept in place?Yes
- Measures
- Prevention
Information gathering on the topic
Training of employees
Education
Code of conduct with rules for treating children and young people with respect
- Last review of the measure
01.09.2023 17:16:12
Age-appropriate complaint options
Special requirements for the selection of persons
Other aspects of prevention
- Last review of the measure
- Intervention
Intervention plan - Binding procedure for dealing with child protection cases and in particular suspected (sexual) violence
- Last review of the measure
01.09.2023 17:16:12
Other aspects of intervention
- Last review of the measure
- Reprocessing
Recommendations for dealing with/processing cases that have occurred
- Last review of the measure
01.09.2023 17:16:12
Other information on recognition
- Last review of the measure
- Prevention
Commentary on the protection concept
Gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie haben sich Einrichtungen, die Kinder und Jugendliche versorgen, gezielt mit der Prävention von und Intervention bei (sexueller) Gewalt und Missbrauch bei Kindern und Jugendlichen zu befassen (Risiko- und Gefährdungsanalyse) und – der Größe und Organisationsform der Einrichtung entsprechend – konkrete Schritte und Maßnahmen abzuleiten (Schutzkonzept). In diesem Abschnitt geben Krankenhäuser, die Kinder und Jugendliche versorgen, an, ob sie gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie ein Schutzkonzept gegen (sexuelle) Gewalt bei Kindern und Jugendlichen aufweisen.
- Complaint management
- Participation emergency care
Drug therapy safety
Steering committee
- Drug commission
Training of employees on AMTS related topics
Availability of appropriate, topic-specific informational materials for patients on AMTS e.g. for chronic diseases, for high-risk drugs, for children
Electronic support for the admission and anamnesis process (e.g. import of patient master data or medication plans, use of a drug knowledge database, input screen for drugs or anamnesis information)
Provision of one or more electronic drug information systems (e.g. Lauer-Taxe®, ifap klinikCenter®, Gelbe Liste®, Fachinfo-Service®)
Concepts for ensuring the error-free preparation of medications
- Bereitstellung einer geeigneten Infrastruktur zur Sicherstellung einer fehlerfreien Zubereitung
- Zubereitung durch pharmazeutisches Personal
- Anwendung von gebrauchsfertigen Arzneimitteln bzw. Zubereitungen
- Zubereitung in der Apotheke: ausgewählte Präparate bzw. für ausgewählte Bereiche (Zytostatika, Kinderklinik, spezielle Parenteralia zur Schmerztherapie) und Einzelrezepturen, Bereitstellen von gebr
Electronic support for the supply of patients with drugs
- Vorhandensein von elektronischen Systemen zur Entscheidungsunterstützung (z.B. Meona®, Rpdoc®, AIDKlinik®, ID Medics® bzw. ID Diacos® Pharma)
- AidKlinik, elektronisches Apotheker-Konsil auf Anforderung
Measures to minimise medication errors
- Fallbesprechungen
- Maßnahmen zur Vermeidung von Arzneimittelverwechslung
- Spezielle AMTS-Visiten (z. B. pharmazeutische Visiten, antibiotic stewardship, Ernährung)
- Teilnahme an einem einrichtungsübergreifenden Fehlermeldesystem (siehe Kapitel 12.2.3.2)
- pharmazeutische Visiten auf Projektstationen, Prüfung von Medikationsplänen auf Anforderung, ABS-Visiten durch interdisziplinäres Team, Bereitstellen von Infoblättern zu verschiedenen Arzneimittel-be
Measures to ensure seamless drug therapy after discharge
- Aushändigung von arzneimittelbezogenen Informationen für die Weiterbehandlung und Anschlussversorgung der Patientin oder des Patienten im Rahmen eines (ggf. vorläufigen) Entlassbriefs
- Aushändigung von Patienteninformationen zur Umsetzung von Therapieempfehlungen
- Aushändigung des Medikationsplans
- bei Bedarf Arzneimittel-Mitgabe oder Ausstellung von Entlassrezepten
Instruments and measures
The instruments and measures to promote drug therapy safety are presented with a focus on the typical procedures of the medication process in inpatient patient care. A special feature of the medication process in the inpatient environment is the transition management during admission and discharge. The instruments and measures listed below address structural elements, e.g. special IT equipment and work materials, as well as process aspects, such as work descriptions for particularly risky process steps or concepts for securing typical risk situations . In addition, proven measures to avoid or learn from medication errors can be specified. The hospital presents here which aspects it has already dealt with and which measures it has specifically implemented. The following aspects can be presented, if necessary using free text fields:
- Admission to hospital, including anamnesis
; Instruments and measures are presented for determining the old medication (drug history), the subsequent clinical assessment and the switch to the medication available in the hospital (house list), as well as for documenting both the patient's original medication and that for hospital treatment adapted medication.
- Medication process in the hospital
In this context, the following sub-processes are assumed as examples: drug history - prescription - patient information - drug delivery - drug use - documentation - therapy monitoring - result assessment. Instruments and measures for safe medication prescription can be presented, e.g. B. in terms of readability, clarity and completeness of the documentation, but also in terms of area of application, effectiveness, benefit-risk ratio, tolerability (including potential contraindications, interactions, etc.) and resource considerations. Information can also be provided to support reliable medication ordering, delivery and use or administration.
- Discharge
In particular, the measures taken by hospitals can be presented to ensure that information on drug therapy is structured and passed on to doctors and physicians providing further treatment, as well as the appropriate provision of patients with drug information, medication plans and medications. Drug prescriptions are made.
AMTS is the totality of measures to ensure an optimal medication process with the aim of reducing medication errors and thus avoidable risks for patients during drug therapy. A prerequisite for the successful implementation of these measures is that AMTS is practised as an integral part of daily routine in an interdisciplinary and multi-professional approach.
- Special instrument-based equipment
Job
FL09 - Doctoral supervision
Explanation
FL03 - Student training (clinical traineeship / internship year)
Explanation
Akademisches Lehrkrankenhaus der Paracelsus Medizinischen Privatuniversität. Das Studium der Humanmedizin wird von der Paracelsus Medizinischen Privatuniversität am Klinikum Nürnberg. Das Hebammenstudium wird in Zusammenarbeit mit der TH Nürnberg angeboten.
FL02 - Lectureships / teaching posts at universities of applied sciences
Explanation
FL04 - Project-related cooperation with colleges and universities
Explanation
FL05 - Participation in multi-centre Phase I/II studies
Explanation
FL06 - Participation in multi-centre phase III/IV studies
Explanation
FL07 - Initiation and management of uni-centric/multi-centric clinical/scientific studies
Explanation
FL08 - Editors of scientific journals/textbooks
Explanation
FL01 - Lectureships / teaching posts at colleges and universities
Explanation
Training
Training in other healing professions
HB15 - Anaesthesia technical assistant (m/f)
Comment
HB03 - Physical therapist / physiotherapist (m/f)
Comment
HB05 - Medical technical radiology assistant (MTRA) (m/f)
Comment
HB01 - Nurse and health care worker (m/f)
Comment
HB06 - Occupational therapist (m/f)
Comment
HB02 - Health and paediatric nurse (m/f)
Comment
HB09 - Speech therapist (m/f)
Comment
HB17 - Auxiliary nurse (m/f)
Comment
HB07 - Surgical technical assistant (m/f)
Comment
HB18 - Emergency paramedics (m/f) (training period 3 years)
Comment
HB10 - Midwife (m/f)
Comment
HB19 - Nursing professionals
Comment
HB12 - Medical technical laboratory assistant (MTLA) (m/f)
Comment
- Hospital staff
- Number of doctors: 510,90
- Total number of nurses: 1.295,30
- Number of therapeutic staff: 1.623,70
Pharmaceutical personnel
- Number of pharmacists: 4
- Additional staff: 13
- Explanations: Die Apotheke des Kliniku*ms befindet sich im Klinikum Nürnberg Süd, von dort aus erfolgt die Versorgung mit allen Arzneimitteln außer Zytostatika; ein Teil der MA befindet sich zur Sicherstellung der Versorgung im KNN (hier werden auch die Zytostatika hergestellt)
- Nursing staff regulation
Service contact persons
Patient advocates
Julia Freund
Patientenfürsprecherin
Prof.-Ernst-Nathan-Str. 1
90419 Nürnberg
Phone: 0911 -3982701-
Mail: ed.grebnreun-mukinilk@tnemeganamedrewhcseb
Hans Makilla
Patientenfürsprecher
Prof.-Ernst-Nathan-Str. 1
90419 Nürnberg
Phone: 0911 -3982701-
Mail: ed.grebnreun-mukinilk@tnemeganamedrewhcseb
Gerlinde Mathes
Patientenfürsprecherin
Prof.-Ernst-Nathan-Str. 1
90419 Nürnberg
Phone: 0911 -3982701-
Mail: ed.grebnreun-mukinilk@tnemeganamedrewhcseb
Lemia Yiyit
Patientenfürsprecherin
Prof.-Ernst-Nathan-Str. 1
90419 Nürnberg
Phone: 0911 -3982701-
Mail: ed.grebnreun-mukinilk@tnemeganamedrewhcseb
Britta Bungartz
Patientenfürsprecherin
Prof.-Ernst-Nathan-Str. 1
90419 Nürnberg
Phone: 0911 -3982701-
Mail: ed.grebnreun-mukinilk@tnemeganamedrewhcseb
Avci Cengiz
Patientenfürsprecherin
Prof.-Ernst-Nathan-Str. 1
90419 Nürnberg
Phone: 0911 -3982701-
Mail: ed.grebnreun-mukinilk@tnemeganamedrewhcseb
Customer feedback management
Gertrud E. Müller
Beschwerdemanagement
Prof.-Ernst-Nathan-Str. 1
90419 Nürnberg
Phone: 0911 -3983773-
Mail: ed.grebnreun-mukinilk@tnemeganamedrewhcseb
Angelika Erhardt
Beschwerdemanagement
Prof.-Ernst-Nathan-Str. 1
90419 Nürnberg
Phone: 0911 -3983773-
Mail: ed.grebnreun-mukinilk@tnemeganamedrewhcseb
Anja Arampatzis
Beschwerdemanagement
Prof.-Ernst-Nathan-Str. 1
90419 Nürnberg
Phone: 0911 -3983773-
Mail: ed.grebnreun-mukinilk@tnemeganamedrewhcseb
Quality management
Dr. Michael Krause
Ärztliches Qualitätsmanagement
Prof.-Ernst-Nathan-Str. 1
90419 Nürnberg
Phone: 0911 -3983521-
Mail: ed.grebnreun-mukinilk@esuark.leahcim
Kai Ullrich
Qualitätsmanagement
Prof.-Ernst-Nathan-Str. 1
90419 Nürnberg
Phone: 0911 -398-7446
Mail: ed.grebnreun-mukinilk@hcirllu.iak
Hygiene officer
Prof. Dr. med. Achim Jockwig
Vorstandsvorsitzender
Prof.-Ernst-Nathan-Str. 1
90419 Nürnberg
Phone: 0911 -398-3501
Mail: ed.grebnreun-mukinilk@giwkcoj.mihcA
Responsible for drug therapy
Dr. Annette Sattler
Leitende Apothekerin
Prof.-Ernst-Nathan-Str. 1
90419 Nürnberg
Phone: 0911 -3982550-
Mail: ed.grebnreun-mukinilk@relttaS.ettennA
Accessibility Officer
Gertrud E. Müller
Ansprechpartnerin für Menschen mit Beeinträchtigung
Prof.-Ernst-Nathan-Str. 1
90419 Nürnberg
Phone: 0911 -3983493-
Mail: ed.grebnreun-mukinilk@relleum.e.durtreG
Company
General contact details of the hospital
Prof.-Ernst-Nathan-Str. 1
90419 Nürnberg
Phone:0911-3980
Mail:ed.grebnreun-mukinilk@elletsesserp
Nursing service management
Peter Schuh
Vorstand – zuständig für Personal und Patientenversorgung
Prof.-Ernst-Nathan-Str. 1
90419 Nürnberg
Phone: 0911 -3983510-
Mail: ed.grebnreun-mukinilk@huhcs.retep
Head of administration
Prof. Dr. Achim Jockwig
Vorstandsvorsitzender
Prof.-Ernst-Nathan-Str. 1
90419 Nürnberg
Phone: 0911 -3983501-
Mail: ed.grebnreun-mukinilk@dnatsrov
Dr. Andreas Becke
Vorstand – zuständig für Infrastruktur und Finanzen
Prof.-Ernst-Nathan-Str. 1
90419 Nürnberg
Phone: 0911 -3983503-
Mail: ed.grebnreun-mukinilk@ekceb
Responsible for the quality report in the hospital management
Prof. Dr. Achim Jockwig
Vorstandsvorsitzender
Prof.-Ernst-Nathan-Str. 1
90419 Nürnberg
Phone: 0911 -3983501-
Mail: ed.grebnreun-mukinilk@dnatsrov
Medical management
Prof. Dr. Achim Jockwig
Vorstand – zuständig für Medizin und Entwicklung
Prof.-Ernst-Nathan-Str. 1
90419 Nürnberg
Phone: 0911 -3983501-
Mail: ed.grebnreun-mukinilk@dnatsrov
Regional care obligation for psychiatry?
No
IK number
IK: 260950099
Location number
Location number: 771374000
Old location number: 771374000
Hospital portrait for download
